This month's @BCAbloodcenters #AdvancedTherapy News is now out featuring the @AllofUsResearch program, decentralized manufacturing, outpatient #celltherapy admin, and much more! mailchi.mp/22a03f70c083/adva… Thanks to @getbiolinked for sponsoring @accellix for the special offer.

#isct2024 #productlaunch

#ISCT2024 #productlaunch

Join the Decentralized Manufacturing Working Group tomorrow for a discussion on Regulatory Challenges! events.teams.microsoft.com/e…

Did you catch this @BioProcessIntl piece by Brent Morse and Alicja Fiedorowicz? "Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 1 — In-Process and Drug Product Control." Read now, here! bioprocessintl.com/cell-ther…

More momentum on the #POC manufacturing front. Enter, regional blood banks. @GalapagosGlobal @BCAbloodcenters glpg.com/press-releases/gala…

Aiming to decentralize CAR-T manufacturing, @GalapagosGlobal partners with largest US blood supply network - endpts.com/aiming-to-decentr…

#decentralized #manufacturing #celltherapy #cart #advancedtherapies @Phacilitate @ISCTglobal @AABB @ASGCTherapy @alliancerm

Fulfilling the promise of cell & gene therapies through manufacturing (Part I) fiercepharma.com/manufacturi…

Please note @LeeBuckler4 is a fake account. Please report it and block it. #fakeaccount. Thank you @DrPHanley for alerting me.

NY Governor Releases Request for Proposals for State-of-the-Art Cell and Gene Therapy Hub on Long Island. More Than $150M Available Builds on Governor’s Commitment to Boosting Fast Growing Sectors Like Life Sciences — Including State Commitment to Establishing Two Cell and Gene Therapy Hubs New Hub Will Help to Position New York State as National Leader in Cell and Gene Therapies governor.ny.gov/news/governo…

I did not see this one coming, congrats to patients in Bahrain!

Wow. Thank you #sfo for transforming the airport experience. 🙏🏼🧘🏼‍♂️💙

If you have not participated in the @US_FDA's crowdsourcing initiative: Envisioning the Future for Biological Products, then get to it! You have 2 days left. Bring your insights and expertise to CBER’s crowdsourcing community designed to share ideas, solutions, and visions for the future of biologics. The goal of this crowdsourcing initiative is to gather external ideas on major advances in product development for CBER-regulated products, including novel products and product manufacturing methods that are likely to emerge in the next 3-10 years. fda-cber.ideascalegov.com/c/…

A panel of independent experts on Wednesday recommended that @FDACBER reject an experimental ALS #celltherapy, known as #NurOwn, developed by the biotech @BrainstormCell. The FDA has until Dec. 8 to approve or reject the drug endpts.com/fda-panel-recomme…

On the 27th, the @FDACBER CTG Therapies Adv Comm will meet in open session to discuss and make recommendations on @BrainstormCell's biologics license application for debamestrocel (autologous bone marrow-derived MSC #celltherapy) for the treatment of amyotrophic lateral sclerosis (ALS). fda.gov/advisory-committees/…

BioCardia unveils interim data that led it to stop PhIII enrollment of heart failure stem cell therapy - endpts.com/biocardia-unveils…

What is this the 3rd time around? Maybe they should have listened to the FDA the first time or second time. _____ Mesoblast's CEO takes 30% pay cut to fund 3rd shot at cell therapy approval fiercebiotech.com/biotech/me…

Despite the obfuscating press release, the short of it for @biocardia $BCDA, is the DSMB did a futility analysis and concluded the ph 3 trial was unlikely to meet the PE but mgmt convinced them to pause the trial pending the 12-month outcomes analysis. markets.businessinsider.com/…

If you've ever thought analytical technologies for #celltherapies are a black hole, then we aim to crowdsource you some answers. We've launched a project trying to shed some light on existing and up-and-coming analytical technologies. Help us help you. docs.google.com/forms/d/e/1F…